Codes / ICD10CM / T65.1X2

T65.1X2 Toxic effect of strychnine and its salts, intentional self-harm

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic Effect of Strychnine and Its Salts, Intentional Self-Harm

Summary

This condition describes adverse health effects resulting from intentional self-harm involving exposure to strychnine or its salts. Strychnine is a highly toxic alkaloid that can cause severe neurological and muscular effects. Intentional exposure may occur through ingestion, inhalation, or skin contact, leading to acute toxicity.

Causes

The toxic effect is caused by intentional self-harm involving exposure to strychnine or its salts. Common sources include rodenticides, contaminated substances, or other materials containing strychnine. Intentional ingestion, inhalation, or dermal contact with strychnine-containing products can lead to poisoning.

Risk Factors

  • Intentional self-harm or suicidal behavior.
  • Access to strychnine-containing substances (e.g., rodenticides).
  • History of mental health conditions or substance use disorders.
  • Lack of supervision or support in high-risk environments.

Symptoms

  • Rapid onset of muscle spasms, stiffness, and rigidity.
  • Severe convulsions, respiratory distress, or paralysis.
  • Hyperreflexia, agitation, or loss of consciousness.
  • Potential for cardiac arrest or respiratory failure in severe cases.

Diagnosis

Diagnosis is based on clinical presentation, history of intentional exposure, and laboratory tests. Toxicology screening may detect strychnine levels, and clinicians assess for signs of self-harm or suicidal intent. Imaging or other tests may rule out alternative causes.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and preventing further harm. Interventions may include airway support, anticonvulsants, and decontamination. Psychological evaluation and support are critical for addressing underlying intent.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of treatment, and severity of symptoms. Early intervention improves outcomes, but severe cases may result in long-term neurological damage or death. Follow-up includes monitoring for complications and addressing mental health needs.

Complications

  • Respiratory failure or cardiac arrest.
  • Permanent neurological damage (e.g., muscle weakness, paralysis).
  • Recurrent seizures or chronic pain.
  • Psychological sequelae related to self-harm.

Lifestyle & Prevention

  • Secure storage of strychnine-containing products.
  • Education on toxicity and safe handling.
  • Access to mental health resources for at-risk individuals.
  • Restriction of access to harmful substances in high-risk settings.

When to Seek Professional Help

Seek immediate medical attention if exposure to strychnine is suspected, especially with intentional self-harm. Symptoms like muscle spasms, convulsions, or difficulty breathing require urgent care. Mental health support should be sought for underlying concerns.

Tips for Medical Coders

Document the intent of exposure (intentional self-harm) and clinical details supporting the diagnosis. Include notes on the route of exposure, severity, and any associated mental health assessments. Ensure documentation aligns with the code’s specificity for intentional self-harm.

Book a walkthrough

T65.1X2 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.